国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Cuscuta gronovii Cytochrome b6-f complex subunit 5 (petG), partial CSB-YP418364CXR
CSB-EP418364CXR
CSB-BP418364CXR
CSB-MP418364CXR
CSB-EP418364CXR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cuscuta gronovii Plastid 30S ribosomal protein S11 (rps11) CSB-YP418365CXR
CSB-EP418365CXR
CSB-BP418365CXR
CSB-MP418365CXR
CSB-EP418365CXR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cuscuta gronovii 50S ribosomal protein L2, plastid (rpl2) CSB-YP418366CXR
CSB-EP418366CXR
CSB-BP418366CXR
CSB-MP418366CXR
CSB-EP418366CXR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cuscuta reflexa ATP synthase subunit alpha, plastid (atpA), partial CSB-YP418367CXT
CSB-EP418367CXT
CSB-BP418367CXT
CSB-MP418367CXT
CSB-EP418367CXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cuscuta reflexa Cytochrome b6-f complex subunit 8 (petN), partial CSB-YP418368CXT
CSB-EP418368CXT
CSB-BP418368CXT
CSB-MP418368CXT
CSB-EP418368CXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cuscuta reflexa Photosystem II reaction center protein J (psbJ), partial CSB-YP418369CXT
CSB-EP418369CXT
CSB-BP418369CXT
CSB-MP418369CXT
CSB-EP418369CXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cuscuta reflexa ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP418370CXT
CSB-EP418370CXT
CSB-BP418370CXT
CSB-MP418370CXT
CSB-EP418370CXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cuscuta reflexa 50S ribosomal protein L16, plastid (rpl16) CSB-YP418371CXT
CSB-EP418371CXT
CSB-BP418371CXT
CSB-MP418371CXT
CSB-EP418371CXT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio UPF0764 protein C16orf89 homolog CSB-YP418372DIL
CSB-EP418372DIL
CSB-BP418372DIL
CSB-MP418372DIL
CSB-EP418372DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Acylphosphatase (acyP) CSB-YP418373CXL
CSB-EP418373CXL
CSB-BP418373CXL
CSB-MP418373CXL
CSB-EP418373CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Glucans biosynthesis glucosyltransferase H (mdoH), partial CSB-YP418374CXL
CSB-EP418374CXL
CSB-BP418374CXL
CSB-MP418374CXL
CSB-EP418374CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii tRNA (cmo5U34)-methyltransferase CSB-YP418375CXL
CSB-EP418375CXL
CSB-BP418375CXL
CSB-MP418375CXL
CSB-EP418375CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii tRNA (guanine-N (1)-)-methyltransferase CSB-YP418376CXL
CSB-EP418376CXL
CSB-BP418376CXL
CSB-MP418376CXL
CSB-EP418376CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP418377CXL
CSB-EP418377CXL
CSB-BP418377CXL
CSB-MP418377CXL
CSB-EP418377CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP418378CXL
CSB-EP418378CXL
CSB-BP418378CXL
CSB-MP418378CXL
CSB-EP418378CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Alkanesulfonate monooxygenase (ssuD) CSB-YP418379CXL
CSB-EP418379CXL
CSB-BP418379CXL
CSB-MP418379CXL
CSB-EP418379CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii 23S rRNA (uracil (747)-C (5))-methyltransferase RlmC CSB-YP418380CXL
CSB-EP418380CXL
CSB-BP418380CXL
CSB-MP418380CXL
CSB-EP418380CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii HTH-type transcriptional repressor PurR (purR) CSB-YP418381CXL
CSB-EP418381CXL
CSB-BP418381CXL
CSB-MP418381CXL
CSB-EP418381CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Trigger factor (tig) CSB-YP418382CXL
CSB-EP418382CXL
CSB-BP418382CXL
CSB-MP418382CXL
CSB-EP418382CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cronobacter sakazakii Glyoxylate/hydroxypyruvate reductase A (ghrA) CSB-YP418383CXL
CSB-EP418383CXL
CSB-BP418383CXL
CSB-MP418383CXL
CSB-EP418383CXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>